This compound is a protected amino acid derivative featuring a fluorenylmethoxycarbonyl (Fmoc) group and a tert-butyl ether. It serves as a pharmaceutical intermediate, primarily used in solid-phase peptide synthesis as a building block.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 3020708-11-3
Fmoc-4-tert-butoxy-L-proline
research compound
(2S,4R)-4-tert-butoxy-1-(9H-fluoren-9-ylmethoxycarbonyl)piperidine-2-carboxylic acid
pharmaceutical intermediate
(2S,4S)-4-tert-butoxy-1-(9H-fluoren-9-ylmethoxycarbonyl)piperidine-2-carboxylic acid
pharmaceutical intermediate
N3-L-Val-OH (CHA)
pharmaceutical intermediate
Glycinamide hydrochloride
pharmaceutical intermediate
(2R)-1,4-Bis(tert-butoxycarbonyl)piperazine-2-carboxylic acid
pharmaceutical intermediate
L-Aspartic acid di-tert-butyl ester hydrochloride
pharmaceutical intermediate
(2S,3S)-3-tert-butoxy-1-(9H-fluoren-9-ylmethoxycarbonyl)piperidine-2-carboxylic acid
pharmaceutical intermediate
(2S,5R)-1-(9H-fluoren-9-ylmethoxycarbonyl)-5-[(2-methylpropan-2-yl)oxy]piperidine-2-carboxylic acid
XSFVPSLXHLZRHD-ZHRRBRCNSA-N
CC(C)(C)O[C@@H]1CC[C@H](N(C1)C(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24)C(=O)O
—